Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

During the Trading Day
8.26 +0.07 / +0.85%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.16 -0.095 / -1.15%
 
Volume: 6.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues736.0K1.1M4.2M4.2M
 
 
 
 
 
Depreciation And Amortization346.0K398.0K392.0K394.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses13.4M12.3M13.4M16.7M
 
 
 
 
 
Research And Development10.8M10.2M10.5M13.4M
 
 
 
 
 
Total Operating Expenses13.7M12.7M13.8M17.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.0M-11.7M-9.5M-12.9M
 
 
 
 
 
Extraordinary Credit953.0K1.8M----
 
 
 
Extraordinary Charge0.00---12.7M-1.8M
 
 
 
Interest Expense On Debt10.0K10.0K8.0K8.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.0M-9.8M-22.2M-14.5M
 
 
 
 
 
Income Taxes0.000.000.00-4.0K
 
 
Net Income-12.0M-9.8M-22.2M-14.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.4M43.4M46.9M50.1M
 
 
 
 
 
Shares To Calculate EPS Diluted44.8M43.4M46.9M50.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.29-$0.23-$0.47-$0.29
 
 
 
 
 
EPS Diluted-$0.29-$0.23-$0.47-$0.29